IP Library Granted Patent US 9,668,800
Granted Patent B2
US 9,668,800 · App. 14/218,925 · Granted Jun 6, 2017

Methods and systems for treatment of spasticity

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,668,800
App. No.
14/218,925
Granted
Jun 6, 2017
Kind
B2
Abstract

A system for alleviating spasticity of a skeletal muscle having an associated motor nerve. The system may include a needle probe having at least one needle. The at least one needle has a proximal end, a distal end, and a needle lumen therebetween. The needle is configured for insertion proximate to the nerve. A cooling fluid supply lumen can extend distally within the needle lumen to a distal portion of the needle lumen. A cooling fluid source is couplable to the cooling fluid supply lumen to direct cooling fluid flow into the needle lumen. A controller having at least one processor configured to implement a spasticity treatment algorithm for controlling the cooling fluid source so that liquid from the cooling flow vaporizes within the needle lumen to provide a treatment phase to the motor nerve such spasticity of the skeletal muscle is mitigated.

Claims (22)

1. A method for alleviating spasticity of a skeletal muscle in a limb of a patient, the skeletal muscle having an associated motor nerve, the method comprising:

positioning a distal end of a cryogenic cooling needle probe proximal to the motor nerve in the limb of the patient, the cryogenic cooling needle probe having at least one needle with a lumen; and

delivering a treatment to a target tissue with the cryogenic cooling needle probe, the treatment comprising a cooling phase where cooling fluid flows into the needle lumen so that liquid from the cooling flow vaporizes within the needle lumen to provide cooling to the motor nerve such that spasticity of the skeletal muscle in the limb of the patient is mitigated while maintaining intentional motor control of the skeletal muscle.

2. The method of claim 1 , further comprising providing a degree of skin warming throughout the delivery of the treatment.

3. The method of claim 2 , wherein the degree of skin warming comprises 28-42° C. of skin warming throughout the treatment.

4. The method of claim 1 , wherein the cryogenic cooling needle probe further comprises a heating element coupled with a proximal portion of the at least one needle; and wherein the treatment further comprises at least one heating phase.

5. The method of claim 4 , wherein the at least one heating phase comprises a pre-heat phase with the heating element before the cooling phase.

6. The method of claim 5 , wherein the pre-heat phase has a duration of 2-20 seconds.

7. The method of claim 5 , wherein the cooling phase has a duration of 15-120 seconds after the pre-heat phase.

8. The method of claim 7 , wherein the at least one heating phase further comprises a post-heat phase.

9. The method of claim 8 , wherein the post-heat phase has a duration of 5-15 seconds.

10. The method of claim 1 , wherein the at least one needle comprises a length of 10-20 mm.

11. The method of claim 1 , wherein the cryogenic cooling needle probe comprises a pair of needles spaced apart such that one needle is placed on one side of the motor nerve and the other needle is placed on an opposite side of the motor nerve.

12. The method of claim 1 , wherein one or a combination of transcutaneous electrical nerve stimulation, percutaneous electrical nerve stimulation, and ultrasound is used to locate the motor nerve.

13. The method of claim 1 , wherein during the cooling phase the cryogenic cooling needle probe generates a cryozone having a volume of 65-125 mm 3 .

14. The method of claim 1 , wherein the at least one needle comprises a length of 30-100 mm.

15. A method for alleviating spasticity of a skeletal muscle having an associated motor nerve, the method comprising:

positioning a distal end of a cryogenic cooling needle probe proximal to the motor nerve such that a first needle of the cryogenic cooling needle probe having a first lumen is proximal to one side of the motor nerve and a second needle of the cryogenic cooling needle probe spaced apart from the first needle and having a second lumen is proximal to an opposite side of the motor nerve so as to straddle the motor nerve with the first and second needles, wherein the first needle and the second needle are spaced apart in a range of 3 mm to 7 mm;

delivering a treatment to a target tissue with the cryogenic cooling needle probe, the treatment comprising a cooling phase where cooling fluid flows into each of the first and second needle lumens so that liquid from the cooling flow vaporizes within each of the first and second needle lumens to provide cooling to the motor nerve such that spasticity of the skeletal muscle is mitigated.

16. The method of claim 15 , wherein the first needle and the second needle have a length that is at least 12 mm.

17. The method of claim 15 , wherein one or a combination of transcutaneous electrical nerve stimulation, percutaneous electrical nerve stimulation, and ultrasound is used to locate the motor nerve.

18. The method of claim 15 , further comprising providing a degree of skin warming throughout the delivery of the treatment.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Dec 5, 2025
From: JPMORGAN CHASE BANK, N.A.
To: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; PACIRA THERAPEUTICS, INC. (F/K/A FLEXION THERAPEUTICS, INC.)
Reel/Frame 073779/0532 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Mar 31, 2023
From: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; PACIRA THERAPEUTICS, INC. (F/K/A FLEXION THERAPEUTICS, INC.)
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 063214/0108 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Mar 31, 2023
From: JPMORGAN CHASE BANK, N.A.
To: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; PACIRA THERAPEUTICS, INC. (F/K/A FLEXION THERAPEUTICS, INC.)
Reel/Frame 063213/0864 →
SUPPLEMENTAL CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Dec 14, 2021
From: PACIRA CRYOTECH, INC.; PACIRA PHARMACEUTICALS, INC.; FLEXION THERAPEUTICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 058516/0636 →
CONFIRMATORY ASSIGNMENT Recorded Jul 15, 2019
From: MYOSCIENCE, INC.
To: PACIRA CRYOTECH, INC.
Reel/Frame 049758/0028 →
RELEASE OF SECURITY INTEREST Recorded Feb 4, 2019
From: VENTURE LENDING & LEASING VII, INC.
To: MYOSCIENCE, INC.
Reel/Frame 048237/0168 →
CORRECTIVE ASSIGNMENT TO CORRECT TO REMOVE APPLICATION NUMBER 12160639 PREVIOUSLY RECORDED AT REEL: 034557 FRAME: 0073. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Dec 29, 2014
From: MYOSCIENCE, INC.
To: VENTURE LENDING & LEASING VII, INC.
Reel/Frame 034713/0226 →
SECURITY INTEREST Recorded Dec 19, 2014
From: MYOSCIENCE, INC.
To: VENTURE LENDING & LEASING VII, INC.
Reel/Frame 034557/0073 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2014
From: KARNIK, JWALA; CARNELL, CLINT; ROSEN, JESSE; ALLISON, JOHN
To: MYOSCIENCE, INC.
Reel/Frame 034086/0005 →